Indi Molecular Lands $1,500,000 Seed Funding

  • Feed Type
  • Date
    9/21/2013
  • Company Name
    Indi Molecular
  • Mailing Address
    6162 Bristol Parkway Culver City, CA 90230
  • Company Description
    Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
  • Website
    http://www.indimolecular.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    The funds will be used to further develop PCC (protein catalyzed capture) agent technology: a breakthrough process that produces synthetic peptide molecules capable of binding interactions that are equivalent or superior to molecular antibodies.
  • M&A Terms
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.